SPY
752.51
−0.02%
QQQ
678.22
−0.17%
BTC/USD
74,778.30
−0.64%
DIA
523.41
+0.02%
GLD
377.85
−0.44%
TLT
81.84
−0.15%
Try
Free
US
Sign in
Register
My Account
Benzinga
Premium Services
Services
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Nyxoah SA
NYXH
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.8940
0.0484
5.72%
Last update: Nov 9, 9:29 AM
Get Report
Overview
News
Earnings Forecast
Events
Price Targets
Financials
Sentiment
Compare
Stock Report
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Earnings:
Q3 2026 Earnings were released on Thu Nov 5th, after the market close
Conference Call:
The most recent conference call started at 4:30 PM, 5 days ago
Click to view the webcast
Nyxoah Financials
Nyxoah (NYXH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Nyxoah Sees FY 2026 Global Net Revenue of €33M to €35M
Nyxoah (NASDAQ:NYXH) Sees FY 2026 Global Net Revenue of €33M to €35M
Benzinga Newsdesk
PRO
Nyxoah Q3 EPS $(0.20) Beats $(0.24) Estimate, Sales $10.554M Miss $11.110M Estimate
Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.24) by 16.67 percent. This is a 72.22 percent increase over losses of $(0.72) per share from the same
Benzinga Newsdesk
PRO
Nyxoah Lowers FY2026 Sales Guidance from $42.156M-$46.840M to $41.852M-$46.502M vs $44.410M Est
Nyxoah (NASDAQ:NYXH) lowers FY2026 sales outlook from $42.156 million-$46.840 million to $41.852 million-$46.502 million vs $44.410 million estimate.
Benzinga Newsdesk
PRO
Nyxoah Q2 EPS $(0.67) Misses $(0.47) Estimate, Sales $8.922M Miss $9.030M Estimate
Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.47) by 42.55 percent. This is a 8.06 percent decrease over losses of $(0.62) per share from the same
Benzinga Newsdesk
PRO
Nyxoah Reports Preliminary Q2 Global Net Revenue Of ~€7.7M, Reiterates FY26 Global Net Revenue Range €36M - €40M
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through
Benzinga Newsdesk
PRO
Nyxoah Sees FY2026 Sales $42.156M-$46.840M vs $37.200M Est
Nyxoah (NASDAQ:NYXH) sees FY2026 sales of $42.156 million-$46.840 million vs $37.200 million analyst estimate.
Benzinga Newsdesk
